Apex Biotechnology Dividende
Zukünftiges Wachstum Kriterienprüfungen 2/6
Apex Biotechnology is a dividend paying company with a current yield of 3.79%.
Wichtige Informationen
3.8%
Dividendenausschüttung
n/a
Rückkaufsrendite
| Gesamte Aktionärsrendite | n/a |
| Zukünftige Dividendenrendite | n/a |
| Wachstum der Dividende | -2.9% |
| Nächster Dividendenzahlungstermin | n/a |
| Ex-Dividendendatum | n/a |
| Dividende pro Aktie | NT$1.100 |
| Ausschüttungsquote | 100% |
Aktuelle Dividendenentwicklung
Recent updates
Apex Biotechnology (TWSE:1733) Will Be Hoping To Turn Its Returns On Capital Around
Aug 06
Apex Biotechnology's (TWSE:1733) Conservative Accounting Might Explain Soft Earnings
Mar 21Apex Biotechnology's (TPE:1733) Returns On Capital Not Reflecting Well On The Business
Apr 17Is Apex Biotechnology (TPE:1733) Using Too Much Debt?
Mar 30Is Apex Biotechnology Corp. (TPE:1733) A Good Fit For Your Dividend Portfolio?
Mar 10Is Apex Biotechnology Corp.'s (TPE:1733) Stock On A Downtrend As A Result Of Its Poor Financials?
Feb 17A Look At Apex Biotechnology's (TPE:1733) Share Price Returns
Jan 27
Returns On Capital At Apex Biotechnology (TPE:1733) Paint An Interesting Picture
Jan 06These 4 Measures Indicate That Apex Biotechnology (TPE:1733) Is Using Debt Safely
Dec 16Is Apex Biotechnology Corp.'s (TPE:1733) 4.5% Dividend Worth Your Time?
Nov 22Stabilität und Wachstum des Zahlungsverkehrs
Rufe Dividendendaten ab
Stabile Dividende: 1733's dividend payments have been volatile in the past 10 years.
Wachsende Dividende: 1733's dividend payments have fallen over the past 10 years.
Dividendenrendite im Vergleich zum Markt
| Apex Biotechnology Dividendenrendite im Vergleich zum Markt |
|---|
| Segment | Dividendenrendite |
|---|---|
| Unternehmen (1733) | 3.8% |
| Untere 25 % des Marktes (TW) | 1.7% |
| Markt Top 25 % (TW) | 4.4% |
| Branchendurchschnitt (Medical Equipment) | 2.8% |
| Analystenprognose (1733) (bis zu 3 Jahre) | n/a |
Bemerkenswerte Dividende: 1733's dividend (3.79%) is higher than the bottom 25% of dividend payers in the TW market (1.71%).
Hohe Dividende: 1733's dividend (3.79%) is low compared to the top 25% of dividend payers in the TW market (4.42%).
Gewinnausschüttung an die Aktionäre
Abdeckung der Erträge: With its high payout ratio (100.4%), 1733's dividend payments are not well covered by earnings.
Barausschüttung an die Aktionäre
Cashflow-Deckung: With its reasonably low cash payout ratio (45.6%), 1733's dividend payments are well covered by cash flows.